김경식 교수 연구실
article|
bronze
·인용수 0
·2025
1092P Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in patients with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: Durable long-term survival from the OPEB-01/APGOT-OV4 trial
Y-N. Kim, Kyung Sik Kim, JW Kim, B-G. Kim, Mei Chin Lim, N.Y.L. Ngoi, D.S. Tan, June‐Yong Lee
IF 65.4Annals of Oncology
키워드
BevacizumabPembrolizumabMaintenance therapyOvarian cancerMonoclonalImmunotherapy